The weekly litigation news digest is live. Subscribe now

IP Verse

Scalable High Recovery Methods For Producing High Yield Recombinant Adeno-Associated Viral (Raav) Vector And Recombinant Adeno-Associated Viral (Raav) Vectors Produced Thereby - EP3488007

The patent EP3488007 was granted to Spark Therapeutics on Dec 20, 2023. The application was filed on Jul 21, 2017 under application number EP17831956A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3488007

SPARK THERAPEUTICS
Application Number
EP17831956A
Filing Date
Jul 21, 2017
Status
Granted And Under Opposition
Nov 17, 2023
Publication Date
Dec 20, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
STRAWMANSep 18, 2024CARPMAELS & RANSFORDADMISSIBLE

Patent Citations (11) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTUS2011165645
INTERNATIONAL-SEARCH-REPORTUS2013072548
INTERNATIONAL-SEARCH-REPORTUS2015275186
INTERNATIONAL-SEARCH-REPORTUS2016024139
OPPOSITIONUS2005153420
OPPOSITIONWO2011094198
OPPOSITIONWO2017100682
SEARCHWO2005118792
SEARCHWO2006087643
SEARCHWO2011094198
SEARCHWO2016128408

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents